Post Categories
QPS Global Clinical Operations Team Aces Enrollment for a Global Study of a Prostate Cancer Drug
April 19, 2016
QPS has been assisting an international Sponsor to perform a global, late-phase study to investigate the safety, efficacy, and pharmacokinetic behavior of an investigational…
SCIEX and QPS Join Forces to Bring You a New Bioanalysis Solution for Biologics
April 5, 2016
Over the past 10 years, large molecule therapies have increased from 10% to nearly 50% of the typical pharma and biopharmaceutical pipeline. This transition…
QPS Now Has Exclusive Distribution Rights for Samsara’s Specialized Human Liver Cells
March 25, 2016
QPS and Samsara Sciences have solidified a cell supply partnership for the production, characterization and distribution of primary human liver cells including hepatocytes and…
QPS will have a strong presence at ASCPT 2016 in San Diego March 9th-11th
March 9, 2016
QPS will have a strong presence at ASCPT 2016 in San Diego March 9th-11th. Several members of QPS’ Early Phase Clinical team will be…
QPS is proud to announce that our toxicology facility passed a GLP audit by the US FDA in 3Q 2015 with no major findings.
March 7, 2016
We are exhibiting at SOT 55th Annual Meeting and ToxExpoTM. Please visit our booth (#1813) between March 13-16 at the New Orleans Convention Center,…
QPS Global Clinical Operations Team Aces Enrollment for Global Study of Prostate Cancer Drug and Completes the First Patient in Europe!
March 2, 2016
QPS has been assisting an international Sponsor to perform a global, late-phase study to investigate the safety, efficacy, and pharmacokinetic behavior of a newly…
QPS will create an (LC)-ICP-MS assay to perform the critical elemental analysis in your drug development study
March 1, 2016
If you need to quantify blood zinc levels, are working on a gadolinium-based MRI contrast agent, or need to measure platinum levels in mouse…
QPS Seen As Inspirational for Delaware
February 25, 2016
Where do you turn when you just took the package? 25% of DuPont employees (likely more on the way) got the bad news here…
Consultation open on revised EMA Guideline on Medicines to treat Alzheimer’s Disease
February 15, 2016
The European Medicines Agency (EMA) has released a draft guideline revision on the clinical investigation of medicines for the treatment of Alzheimer’s disease and…
New ICP-MS Magnesium (Mg) Assays in Human Plasma and Urine added to the QPS Global Assay Database
February 9, 2016
The role of Mg in human nutrition has recently received renewed interest. Mg dietary intake has been reported to have decreased during the last…
See QPS in London at Informa’s Early Clinical Development Conference, 23 – 24 February 2016
February 5, 2016
On February 23, Professor Zuzana Diamant, MD PhD, Director of Respiratory & Allergy Research at QPS, will talk about Biomarkers in Respiratory Drug Development…
Read the QPS Whitepaper on Phase I Site Selection to support EU Registration
January 6, 2016
Making the right decision about where to conduct Phase I of a clinical trial is crucial. As long as basic EU regulatory requirements are…
Changing Our Perspective on “Mind-Altering” Drugs – Part II
July 19, 2022
Developing an effective and safe medicine is a labor of love in any therapeutic area, but perhaps none so much as the central nervous…
Brain Implant Enables Communication in ALS Patient
June 29, 2022
As many as 30,000 people in the United States are currently diagnosed with amyotrophic lateral sclerosis, or ALS. This debilitating neurological condition is caused…
Changing Our Perspective on “Mind-Altering” Drugs – Part I
June 28, 2022
For a generation that grew up with “Just Say No” as a recurring theme, the idea of taking psychedelics with nicknames such as acid…
New Obesity Drug Shows Great Promise in Phase III Trials
June 22, 2022
Danish pharmaceutical giant Novo Nordisk changed the game last year, presenting data that suggested one of the company’s diabetes drugs was also highly effective…
Could a New Gap-Free Human Genome Make Personal DNA Sequencing “Routine” Care?
June 20, 2022
In 2003, while recognizing the 50th anniversary of the discovery of the double helix, researchers announced that the human genome had been sequenced —…
The Potential of a Self-Amplifying mRNA Vaccine Is Heard Loud and Clear
June 13, 2022
Thanks in large part to the efficacy of the Pfizer-BioNTech and Moderna mRNA vaccines, mask mandates, social distancing, and other COVID-19-related precautions have eased…
Introduction Real-world evidence (RWE) is accelerating drug development by using routinely collected patient health data, known as real-world data (RWD), to deliver insights beyond…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
NEWARK, Del.—(BUSINESS WIRE)—QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in…
NEWARK, Del.—(BUSINESS WIRE)—QPS India, a subsidiary of QPS Holdings, LLC (QPS), a GLP/GCP-compliant global full-service Contract Research Organization, has achieved another significant milestone by…
TAIPEI, Taiwan—(BUSINESS WIRE)—QPS, a leading global contract research organization (CRO) specializing in preclinical and clinical drug development services, is pleased to announce the expansion…
